Cunning Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,455
Closed -$1.76M 55
2024
Q3
$1.76M Hold
5,455
0.92% 51
2024
Q2
$1.7M Hold
5,455
0.95% 48
2024
Q1
$1.55M Hold
5,455
0.86% 67
2023
Q4
$1.57M Hold
5,455
0.98% 54
2023
Q3
$1.47M Buy
+5,455
New +$1.36M 0.96% 57
2023
Q2
Sell
-5,455
Closed -$1.27M 80
2023
Q1
$1.32M Hold
5,455
0.9% 69
2022
Q4
$1.43M Buy
+5,455
New +$1.46M 1.01% 59

Other funds holding AMGN

Cunning Capital Partners's AMGN Position: Q4 2024 in Review

Cunning Capital Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 5,455 shares — an estimated $1.76M sold.

Cunning Capital Partners first reported a position in AMGN in Q4 2022 and held it in 7 quarters. The position peaked at $1.76M in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Cunning Capital Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Cunning Capital Partners sold 5,455 Amgen shares in Q4 2024, an estimated $1.76M.
  • Cunning Capital Partners first reported a position in Amgen in Q4 2022 and held it in 7 quarters.
  • Cunning Capital Partners's Amgen position peaked at $1.76M in Q3 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Cunning Capital Partners's 13F filing for Q4 2024, filed 13 Feb 2025.